Product Description
CYCLIZINE (SYE kli zeen) is an antihistamine. It is used to prevent and to treat the nausea, vomiting, or dizziness of motion sickness. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. (Sourced from: https://my.clevelandclinic.org/health/drugs/19014-cyclizine-oral-tablets)
Mechanisms of Action: H1 Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral, Intravenous
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Bangladesh | Canada | Denmark | Egypt | Finland | Germany | Greece | Ireland | Italy | Malta | New Zealand | Norway | Pakistan | Singapore | South Africa | Taiwan | United Arab Emirates | United Kingdom | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
03/11/2026 |
News Article |
Mothers Exposure to Microbes Protect their Newborn Babies Against Infection |
|
03/10/2026 |
News Article |
Spark Biomedical Launches Pivotal Phase II LUNA Trial for Heavy Menstrual Bleeding |
|
03/10/2026 |
News Article |
Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections |
|
03/09/2026 |
News Article |
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer |